Article info
PDFEditorial
Disease activity in ankylosing spondylitis: the global therapeutic target
- Correspondence to Dr Daniel Wendling, Department of Rheumatology, CHRU de Besançon, University Teaching Hospital, Besancon 25030, France; dwendling{at}chu-besancon.fr
Citation
Disease activity in ankylosing spondylitis: the global therapeutic target
Publication history
- Received October 31, 2017
- Revised November 30, 2017
- Accepted December 1, 2017
- First published December 15, 2017.
Online issue publication
October 18, 2019
Article Versions
- Previous version (18 October 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.